Talk to us

Your feedback directly shapes Sporos.

Color Additive Petition From Center for Science in the Public Interest, et al.; Request To Revoke Color Additive Listing for Use of FD&C Red No. 3 in Food and Ingested Drugs | Sporos

← Back to Regulations

← Rule: U.S. Citizenship and Immigration Se…Prev Rule: Federal Acknowledgment of American …Next →

Final Rule

Color Additive Petition From Center for Science in the Public Interest, et al.; Request To Revoke Color Additive Listing for Use of FD&C Red No. 3 in Food and Ingested Drugs

The Food and Drug Administration (FDA or we) is granting a color additive petition submitted by Center for Science in the Public Interest, et al., by repealing the color additive regulations that permit the use of FD&C Red No. 3 in foods (including dietary supplements) and in ingested drugs. The petitioners provided data demonstrating that this additive induces cancer in male rats. Therefore, FDA is revoking the authorized uses in food and ingested drugs of FD&C Red No. 3 in the color additive regulations.

Published

Jan 16, 2025

Effective

Jan 15, 2027

Citation

90 FR 4628

Agencies

2025-00830Color Additive Petition From Center for Science in the Public Interest, et al.; Request To Revoke Color Additive Listing for Use of FD&C Red No. 3 in Food and Ingested Drugs

Federal Register →PDF

Full text not available in our database.

View on Federal Register →

AI Summary

Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.

No document text available yet

Agencies (2)

FDA — Food and Drug Administration

HHS — Health and Human Services Department

Topics

Color additives Cosmetics Drugs

Docket IDs

Docket No. FDA-2023-N-0437

CFR References

21 CFR 74

Document Details

Type: Final Rule
Action: Final amendment; order.
Document #: 2025-00830
Citation: 90 FR 4628
Publication Date: Jan 16, 2025
Effective Date: Jan 15, 2027
Dates: This order is effective January 15, 2027, except for amendatory instruction 4, which is effective January 18, 2028. If any provisions are delayed or stayed by the filing of proper objections, FDA will publish such notification in the Federal Register. Submit either electronic or written objections and requests for a hearing on the order by February 18, 2025. See section X for further information on the filing of objections.
Federal Register Pages: Vol. 90, pp. 4628–4634
Page Views: 12,060

Source Links

Federal Register (HTML)Federal Register (PDF)

←

Rule: U.S. Citizenship and Immigration Se…

Rule: Federal Acknowledgment of American …

→